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Antibiotic  resistance  concerns  have  been  compounded  by a  report  that soil bacteria  can  catabolise  antibi-
otics, i.e.  break  down  and use  them  as a  sole  carbon  source. To  date this has not  been  verified  or
reproduced, therefore  in this study  soil  bacteria were  screened  to  verify and  reproduce  this hypothe-
sis. Survival  in  high  concentrations  of  antibiotics  was  initially  observed;  however,  on  further  analysis
these bacteria  either  did  not  degrade the  antibiotics  or  they used  an  intrinsic  resistance  mechanism  (-
lactamases) to  degrade the  -lactams, as demonstrated  by  high-performance  liquid  chromatography.
These results  did not  verify or  reproduce  the  hypothesis  that  bacteria  subsist on  antibiotics  or catabolise
antibiotics as  previously  reported.  This study identified  that bacteria  with a catabolising  phenotype did
not degrade  streptomycin  or trimethoprim  and therefore  could  not  utilise  the  antibiotics  as a  nutrient
source. Therefore,  we conclude  that soil  bacteria  do not  catabolise  antibiotics.
© 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
1. Introduction
Antibiotic resistance is  emerging as one of the greatest chal-
lenges to human health [1]. Within the past 20 years, antibiotic
resistance has developed from resistance to single classes of antibi-
otics  to multidrug resistance (MDR) and  extensive drug resistance
(XDR) [2]. Catabolism, i.e.  the capacity of bacteria to not  only resist
but  to subsist on antibiotics, has been presented as a  potentially
crucial step in the evolution of antibiotic resistance from MDR and
XDR to untreatable infections. In 2008, a novel hypothesis was
introduced, namely antibiotic catabolism, defined by the identi-
fication of soil bacteria from different phyla that were capable of
degrading and utilising different classes of antibiotics as a sole car-
bon source [3]. Bacterial catabolism of antibiotics is a  concept that
surpasses antibiotic resistance and MDR  in terms of complexity in
treating and managing bacterial infections. Therefore, it  is impor-
tant for the future successful management of antibiotic-treated
bacterial infections that we  are able to distinguish between conven-
tional resistance mechanisms and the ability of bacteria to subsist
on  antibiotics.
Research on antibiotic degradation was reported in the 1970s,
but  the novel study on multiple antibiotic classes catabolised by
soil  bacteria exposed the full extent and distribution of  antibiotic-
degrading genes in the environment [4].  This study has specifically
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led to the scientific belief that soil bacteria contain previously
uncharacterised antibiotic-degrading resistance enzymes and that
soil  bacteria can subsist on antibiotics, with respect to at least
18  different antibiotics [3]. The only resistance-degrading mecha-
nism described prior to this study was  the degradation of -lactam
antibiotics by the -lactamase resistance mechanisms. The charac-
terised  mechanisms of resistance to all other classes of antibiotics
do  not include degradation. This study revolutionised the current
thinking on  how bacteria can resist antibiotics whilst also identify-
ing  soil bacteria as a potentially large reservoir of novel resistance
mechanisms. Antibiotic catabolism would protect the entire bac-
terial community from the inhibitory effects of antibiotics and
concurrently increase the population size as they use the antibiotics
as a  nutrient source.
Although the hypothesis of antibiotic catabolism by soil bacteria
was published 5  years ago, this hypothesis has neither been repro-
duced nor verified. The aims of the current study were therefore to
verify the hypothesis of  soil bacteria subsisting on antibiotics.
2.  Materials and methods
2.1.  Sampling and site descriptions
The soil sampling sites, locations and elevations are described
in  Table 1.  Soil pH was  determined by suspending 1  g of soil in
2.5 mL  of  0.01 M CaCl2 and measuring the pH using a glass elec-
trode [5]. The pH of each soil was  determined three times and the
mean  ±  standard deviation is given in Table 1.
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Table 1
Geographic and descriptive characteristics of the  analysed urban, agricultural and pristine soil  samples.
Sample ID Description Environmental matter Elevation (m)  Latitude Longitude pH (n = 3)
FWS1 Wädenswil Apple Orchard Orchard soil 407 47.2333 8.6667 7.0 ±  0.1
FWS2 Benedictine Abbey Farm soil 880 47.1167 8.75 7.1 ±  0.1
FWS3 Hospital garden Lawn soil 667  46.7167 9.4333 7.3 ±  0
FWS4 Lindau Apple Orchard Orchard soil 485  47.4833 8.2 4.1 ±  0.2
FWS5 Güttingen Apple Orchard Orchard soil 503 47.6 9.2833 5.3 ±  0.1
FWS6 Rütli meadow Meadow soil 835  46.9667 8.6 7.1 ±  0.2
FWS7 Area beside Lake Zürich Lawn soil 408 47.3667 8.55 7.0 ±  0.1
FWS8 Matterhorn mountain trail Alpine soil 1936 46.0167 7.75 7.2 ±  0.1
FWS9 Farmland treated with pig  manure Manured soil 592  47.1833 8.3167 5.7 ±  0.2
FWS10 Mountain near Zürich Mountain forest soil 700 47.3496 8.492 7.0 ±  0
2.2. Sampling strategy
For each sample site, eight soil core samples were combined.
Soil samples consisted of eight soil cores (10 cm  depth) per repli-
cate  taken using a stainless steel corer with an internal diameter of
2.5  cm.  Soil cores were pooled for each replicate in the field. Pooling
of  soil cores is standardly applied in order to obtain more repre-
sentative samples for a certain field plot or  a  specific experimental
treatment [6–8].
2.3. Isolation of antibiotic-catabolising bacteria from Swiss soil
Soil  bacteria with an antibiotic-catabolising phenotype were
isolated and cultured using methods described previously from
ten soils under a  variety of anthropogenic influences from urban,
pristine and farmland soils (Table 1) [3].  Minimal medium [single
carbon source (SCS)] broth cultures of putative catabolising bacteria
were  serially diluted and spread-plated onto SCS agar supple-
mented with the appropriate corresponding antibiotic [3]. Negative
controls comprised SCS agar without antibiotic, inoculated in the
same manner as described by Dantas et al. [3].  The antibiotics tested
comprised penicillin, dicloxacillin, amikacin, cefalexin, kanamycin,
gentamicin, sisomicin, streptomycin, vancomycin, levofloxacin,
ciprofloxacin, sulfamethizole, nalidixic acid, chloramphenicol, d-
cycloserine, cefotaxime, novobiocin, trimethoprim, sulfisoxazole,
tetracycline, erythromycin, colistin and rifampicin. All antibiotics
and  chemicals, except kanamycin and vancomycin (Carl Roth
GmbH and Co. KG, Karlsruhe, Germany), were obtained from Sigma-
Aldrich Chemie GmbH (Buchs, Switzerland).
Two bacteria described as having the capacity to catabolise car-
benicillin and penicillin were obtained from the Dantas group:
CA-S3F-1, Burkholderia sp.; and PE-S2R-1, Burkholderia sp. Due to
unforeseen circumstances in the Dantas laboratory, further isolates
catabolising non--lactam antibiotics could not  be provided.
The abilities of the antibiotic-catabolising bacteria to grow or
survive in sterile-filtered SCS medium without added antibiotics
were investigated. Assimilable organic carbon-free glassware was
prepared as previously described [9].  Bacteria were inoculated
into SCS medium and grown at 22 ◦C  for 3 days. Then, 10 L  was
removed and added to SCS medium with and without antibiotic at a
final concentration of 1 g/L. Total bacterial counts were performed
on  Days 0, 5, 7, 14, 21 and 28 by plate counts on Luria–Bertani (LB)
agar. The total organic carbon and dissolved organic carbon (DOC)
concentrations were determined as previously described [10].
2.4.  Resistance profiling of  antibiotic-catabolising bacteria
The resistance profile of each isolate was determined as previ-
ously described using 1 mg/mL  of  each antibiotic [11].  Antibiotic
susceptibility tests were performed in duplicate. Where there
was a discrepancy between the two results, susceptibility testing
was performed a third time [12,13].  Two consistent susceptibility
results were taken as the final result.
2.5. Bacterial phylogenetic profiling
The phylogenetic profiles of the bacteria were determined as
previously described [3].  Briefly, the variable regions (nucleotides
63–1389) of the 16S rRNA genes were amplified by PCR and
sequenced. The phylogeny of the bacteria based on sequence vari-
ation of  the 16S rRNA genes was identified using BLASTn and the
Greengenes 2011 database. A phylogenetic tree of the bacterial
species based on the 16S rRNA sequences was  constructed using
the neighbour-joining algorithm in ARB [14].
2.6. High-performance liquid chromatography (HPLC)
investigation of bacterial antibiotic degradation
Degradation of carbenicillin (bacteria CA-S3F-1, Burkholderia
sp.), penicillin (bacteria PE-C-1, Pseudomonas sp. and bacteria
PE-S2R-1, Burkholderia sp.), streptomycin (bacteria ST-C-1, Achro-
mobacter sp.) and trimethoprim (bacteria TR-C-1, Pseudomonas sp.)
was  investigated by  HPLC [1] performed using a  Dionex PDA-100
photodiode array detector, Chromeleon v.6.80 software (Dionex,
Idstein, Germany) and the conditions described in Table 2.  Aliquots
(80  L) of cultures grown in SCS medium containing 1  mg/mL  of
antibiotic were inoculated into 20 mL  of SCS medium containing
1  mg/mL  of appropriate antibiotic and incubated at 22 ◦C for 28
days.  SCS–antibiotic medium containing no bacteria was also incu-
bated at  22 ◦C. Then, 1  mL  was removed at  Days 0, 2, 4, 7, 14, 21
and  28 and was analysed in duplicate using HPLC. Following the
initial results of the HPLC experiments, all bacterial isolates were
also inoculated into SCS medium containing no antibiotic as neg-
ative controls at  a  final concentration of 103 or 104 CFU/mL and
incubated at 22 ◦C for 28 days.
2.7. Biological activity of the antibiotic solutions following
incubation with the catabolising bacteria
The biological activities of the trimethoprim and streptomycin
HPLC solutions containing the respective catabolising bacteria from
Days  0, 14 and 28 were investigated using an adaptation of the
antibiotic disk diffusion assay [15].  Staphylococcus aureus ATCC
Table 2
Description of the high-performance liquid chromatography (HPLC) experimental
conditions and columns.
Antibiotic Wavelength
(nm)
Flow rate
(mL/min)
Column
Penicillin 220 0.7 Nucleosil 100-5, C18
Carbenicillin 220 0.7 Nucleosil 100-5, C18
Streptomycin 195 0.7 Nucleosil 100-5, C18
Trimethoprim 250 0.7 Nucleosil 100-5, C18
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Fig. 1. Antibiotic resistance profiles of 140 isolates from ten soils, showing percentage of isolates resistant to  antibiotics at a concentration of 1 mg/mL.
25923 (0.5 McFarland) was spread on LB agar plates. The HPLC solu-
tions (Days 0, 14 and 28) were sterile-filtered and 15 L  was  added
to a sterile filter paper disk on the S.  aureus agar plates. The plates
were incubated at 37 ◦C  and the zone diameters of the disk diffusion
assays were measured after 16 h.
2.8.  Extraction of ˇ-lactamase enzymes and HPLC investigation
of  ˇ-lactam degradation by  the ˇ-lactamase enzymes
Cultures of CA-S3F-1, PE-C-1 and PE-S2R-1 grown in the respec-
tive antibiotic (1 mg/mL)-containing LB broth at  26 ◦C with shaking
overnight were diluted 1 in 10 in antibiotic (1  mg/mL)-containing
LB  broth and incubated for a  further 4 h. The filtered (0.2 m  filters),
washed supernatants were used in the crude -lactamase enzyme
assays using nitrocefin at 100 M at  a  wavelength of 486 nm
[16]. Escherichia coli transformed with pUC19 plasmid (AmpC -
lactamase-producing) was  used as a  positive control. Degradation
of carbenicillin and penicillin was investigated using HPLC in the
same manner as the HPLC antibiotic degradation experiments.
3.  Results
Bacteria presenting a  catabolism phenotype (growth in SCS
medium containing 1 mg/mL  of antibiotic) were isolated from
all ten soil sources consisting of farmland, pristine soil and
urban environments (Table 1).  The antibiotics on which the
bacteria presented a  catabolism phenotype comprised peni-
cillin, dicloxacillin, amikacin, kanamycin, gentamicin, sisomicin,
streptomycin, cefalexin, vancomycin, trimethoprim, cefotaxime,
sulfamethizole and erythromycin, representing many different
classes of antibiotics, including natural, semisynthetic and syn-
thetic. All ten soils contained bacteria presenting a  catabolism
phenotype both to the -lactam antibiotic penicillin and the
macrolide erythromycin. In total, 140 bacteria with an antibiotic-
catabolising phenotype were identified.
Antibiotic resistance profiling of the isolated bacteria identi-
fied that >80% were capable of growth at 1 mg/mL  of almost all
antibiotics (Fig. 1). The pattern and distribution of high-level resis-
tance did not in all cases correspond to the levels of catabolism
against that antibiotic. However, for the fluoroquinolones and
tetracycline, which had low levels of  resistance, no catabolising
isolates were identified. 16S rRNA genetic phylotyping identified
that  the majority of bacteria were Pseudomonadales (n =  67) fol-
lowed by Burkholderiales (n  =  22) (Fig. 2), which were similar to
the phylotypes previously identified [3].  The Actinomycetales were
the  only Gram-positive bacteria identified. All bacterial isolates
were  capable of growth in SCS medium without antibiotic, as this
medium was  not carbon-free as described by Dantas et al. but con-
tained 15 mg  of ethylene diamine tetra-acetic acid (EDTA) per litre
of SCS medium [3]. DOC tests identified a DOC concentration of
8.53  mg/L in the SCS medium [9].  Thus, the medium contained
sufficient carbon without antibiotics to support bacterial growth.
This constituent was overlooked by the seminal study [3].  Growth
of selected strains of bacteria in SCS medium without antibiotics
increased by a  minimum of 2  log growth over 28 days (Fig. 3).
The HPLC experiments were performed to investigate whether
the  antibiotics streptomycin (bacteria ST-C-1, Achromobacter sp.),
trimethoprim (bacteria TR-C-1, Pseudomonas sp.), penicillin (bacte-
ria PE-C-1, Pseudomonas sp. and PE-S2R-1, Burkholderia sp.) and
carbenicillin (bacteria CA-S3F-1, Burkholderia sp.) were degraded
in  the presence of the catabolising bacteria (Fig. 4a). The bacte-
ria used in the penicillin and carbenicillin HPLC experiments
included isolates (bacteria PE-S2R-1 and bacteria CA-S3F-1) previ-
ously reported as antibiotic catabolisers [3].  Three different classes
of  antibiotic, which have different target sites and resistance
mechanisms, were chosen. Streptomycin is a  protein synthesis
pathway inhibitor, trimethoprim is  a dihydrofolate synthesis path-
way  inhibitor, and the -lactams carbenicillin and penicillin are
cell wall synthesis inhibitors. There were no statistically signifi-
cant differences between the concentrations of streptomycin and
trimethoprim antibiotics with and without the bacteria, as deter-
mined by Student’s t-test. Bacteria were viable after 28 days
incubation as tested by growth on LB agar. These results indicated
that  streptomycin and trimethoprim were not degraded over 28
days and the bacteria were still viable at Day 28. These antibi-
otics were not catabolised even though the bacteria presented with
the  same phenotype as previously described antibiotic catabolis-
ers.  The biological activities of streptomycin and trimethoprim at
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Fig. 2. Phylogenetic distribution of 140  bacterial isolates from ten  soils.
Day 28 were investigated using antibiotic disk diffusion assays.
The  diameters of the zones of inhibition did not decrease for
streptomycin or  trimethoprim solutions between 0 and 28 days.
Streptomycin and trimethoprim were as biologically active at Day
28  as at  Day 0,  confirming that they did not lose their biological
activities as would be expected if they were degraded.
The -lactam antibiotics penicillin and carbenicillin degraded
in  the presence and absence of the bacteria. Penicillin and the
-lactam antibiotics are not stable and degrade easily, which is
why  penicillin was  so difficult to produce in large quantities ini-
tially  after its  discovery. The rate and extent of degradation were
higher when the bacteria were present than in the medium lack-
ing bacteria (Fig. 4a). The -lactam antibiotics are the only class
of  antibiotics known to be degraded due to a  resistance mecha-
nism, namely the -lactamases. Pseudomonas and Burkholderia spp.
both contain chromosomally mediated AmpC enzymes capable of
degrading -lactam antibiotics [17,18].
The -lactam-degrading bacteria (PE-C-1, PE-S2R-1 and CA-
S3F-1) were investigated for the production of  -lactam-degrading
-lactamases. Production of -lactamases was confirmed by diges-
tion of nitrocefin as detected by ultraviolet spectrophotometry over
time. The rate of -lactam degradation was determined by  plotting
the absorbance against time for each bacteria. Using these plots, the
slopes of the lines for CA-S3F-1 (carbenicillin), PE-S2R-1 (penicillin)
and PE-C-1 (penicillin) were 0.0642x + 0.1202, 0.0097x  + 0.0977 and
0.0041x  +  0.1278, respectively, indicating that degradation of the
-lactam ring was  fastest by the -lactamase extracted from CA-
S3F-1, followed by PE-S2R-1 and then PE-C-1. Therefore, each
bacteria contained -lactamases capable of degrading the -lactam
ring of the -lactam antibiotics. The concentration of  protein in the
assays was  the same and thus the differences in rates of degradation
were not due to variations in protein (enzyme) concentrations.
Degradation of carbenicillin and penicillin by the extracted
-lactamases was  further investigated by HPLC (Fig. 4b). These
results identified that the -lactamases extracted from PE-S2R-1
(described in a  previous study as a  -lactam cataboliser) digested
Fig. 3. Growth of the five bacteria presenting catabolism phenotypes in  single carbon source (SCS) medium without antibiotic over 28 days. The five bacteria are those used
in the high-performance liquid chromatography (HPLC) experiments: PE-S2R-1, Burkholderia sp.; PE-C-1, Pseudomonas sp.; CA-S3F-1, Burkholderia sp.; ST-C-1, Achromobacter
sp.; TR-C-1, Pseudomonas sp.
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Fig. 4. High-performance liquid chromatography (HPLC) analysis of antibiotic degradation over 28 days in the presence of (a) bacteria and the corresponding antibiotics
and (b) -lactamases and the  corresponding antibiotics in comparison with degradation by the  bacteria. PE-S2R-1, Burkholderia sp.; PE-C-1, Pseudomonas sp.; CA-S3F-1,
Burkholderia sp.; ST-C-1, Achromobacter sp.; TR-C-1, Pseudomonas sp.
penicillin to almost nothing by Day 4. The rate of degradation by
the extracted -lactamase is  almost identical to that of the bacteria
(PE-S2R-1). The -lactamases from CA-S3F-1 and  PE-C-1 showed
a  similar rate of degradation. Therefore, no additional mechanism
other than the antibiotic resistance mechanism (-lactamase) was
required by any of these bacteria to degrade the -lactam antibi-
otics penicillin and carbenicillin.
As streptomycin and trimethoprim were not degraded after 28
days of incubation with the bacteria, concentrations of the five
bacteria used in the HPLC experiments were monitored in SCS
medium without antibiotic over 28 days. The  hypothesis was that
the  bacteria may  be viable at the end of the 28 days but that
they have not grown over the 28 days and thus could survive
in a  non-growing state. The initial bacterial counts ranged from
1.27 × 103 CFU/mL to 1.55 ×  104 CFU/mL (Fig. 3).
4.  Discussion
Reproducibility and verification of  results are vital components
of the basis of scientific discovery. We aimed to reproduce and
verify the discovery of soil bacteria capable of catabolising antibi-
otics [3]. Within the 4  years since this hypothesis was reported, the
paper describing these results has been cited 145 times (Google
Scholar, 28 January 2013). However, the hypothesis has not been
verified or  reproduced. We propose, based on the results of the
current study and a  lack of verified results concurring with the
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hypothesis of soil bacteria catabolising antibiotics, that soil bacte-
ria  do not catabolise the antibiotics and do not use any novel
mechanism of degradation. Using bacteria from the previous study
and from this study, we have identified that the -lactams were
degraded by the well-characterised -lactamase resistance mech-
anism. The soil bacteria do not therefore represent a source of novel
antibiotic-degrading enzymes. This study has also identified that
bacteria with the catabolising phenotype did  not degrade strep-
tomycin or trimethoprim. We propose that no evidence has been
shown to indicate that soil bacteria can degrade any other classes
of  antibiotics. The ‘carbon-free’ medium (SCS) contained 15 mg/mL
EDTA  that, according to Dantas et al., would be sufficient to support
bacterial growth [3]. This was overlooked by the seminal study.
Using the same methodologies as previously reported, this study
has identified soil bacteria with high-level resistance to 14 different
antibiotics from different classes [3]. Bacteria with the same pheno-
type have previously been described as subsisting on  the antibiotics
as a sole carbon source [3].  However, the current study has iden-
tified that bacteria with a  catabolism phenotype did  not degrade
streptomycin or trimethoprim. Resistance to these antibiotics has
to  date been restricted to target site mutation, modification, efflux,
production of an additional target, or  hyperproduction of  the target
site [19]. High-level resistance in Pseudomonas and Burkholde-
ria spp. has been associated with intrinsic resistance to these
antibiotics [20,21]. The -lactam antibiotics were destroyed in the
presence of the soil bacteria, however destruction of the antibi-
otics was due to the production of -lactamases. Production of
-lactamases was first reported in 1940 [22]. There has been,
however, since then no evidence to suggest that production of -
lactamases is linked to the utilisation and  subsistence of bacteria
on antibiotics as a sole carbon source.
Using the same methods and some of the bacteria as the
previous study describing subsistence on antibiotics as a  sole car-
bon source, we come to a contradictory conclusion. We  conclude
that  the bacteria previously described as using antibiotics as a
sole  carbon source have either not  degraded the antibiotics, and
thus  cannot utilise whole antibiotics as a  carbon source, or  have
degraded the antibiotics using well-characterised resistance mech-
anisms, which have not previously been linked to utilisation as a
sole carbon source.
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